biomarker detection
Genialis, Cancer Research Horizons Partner to Predict Drug Responses
CRH will provide colorectal cancer datasets of diverse patient populations that Genialis will use to improve and validate its ResponderID platform.
Precede Biosciences Debuts Chromatin-Based Liquid Biopsy Platform Backed by New Data at ESMO
Premium
The firm has begun working with pharma, using its technology to identify and monitor transcriptionally regulated drug targets. It is also eyeing multiple clinical diagnostic applications.
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
With $13 million in new funding in hand, the small bioinformatics company aims to take on Big Pharma and will look to partner with major molecular labs.